1-3 of 3
Leighton Clancy, BSc PhD
Close
Sort by
Journal Articles

Administration of Third-Party Virus-Specific T-Cells (VST) at the Time of Initial Therapy for Infection after Haemopoietic Stem Cell Transplant Is Safe and Associated with Favourable Clinical Outcomes (the R3ACT-Quickly trial)

David Gottlieb, MBBS, MD FRACP, FRCPA, Wei Jiang, MBBS, BSc, BA, Selmir Avdic, PhD, Leighton Clancy, BSc PhD, Gaurav Sutrave, MBBS, Caroline M Bateman, PhDMBBS,FRACP,FRCPath,MRCP, Elissa Atkins, RN, Adrian Gabriel Selim, MBBS, Vicki Antonenas, BSc, David Collins, RN BSc (HONS) MN MapptMgt, Janine Street, BSc MSc (Hons), Renee Simms, BSc, Peter J. Shaw, MA,FRACP, David Ritchie, MD PhD, Emily Blyth, B. MDHons), FRACP, FRCPA, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 251.
https://doi.org/10.1182/blood-2019-125166
Published: 2019
Journal Articles

Generation of Fungus-Specific T Lymphocytes for Use in HSCT Patients with Invasive Fungal Disease

Gloria Castellano Gonzalez, PhD, Emily Blyth, Leighton Clancy, BSc PhD, David Gottlieb, MBBS, MD FRACP, FRCPA
Journal: Blood
Blood (2017) 130 (Supplement 1): 3186.
https://doi.org/10.1182/blood.V130.Suppl_1.3186.3186
Published: 2017
Journal Articles

Mass Cytometry Reveals the Broad Effect of CMV Reactivation on Adaptive and Innate Immune Recovery in HSCT Patients Undergoing Adoptive T Cell Therapy for Viral Infections

Emily Blyth, Helen Mcguire, Simone Rizzetto, Barbara Withers, Leighton Clancy, BSc PhD, Fabio Luciani, David Gottlieb, MBBS, MD FRACP, FRCPA
Journal: Blood
Blood (2017) 130 (Supplement 1): 4501.
https://doi.org/10.1182/blood.V130.Suppl_1.4501.4501
Published: 2017